Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB [Phase 3]

View source ↗

Summary

Phase III study to evaluate the efficacy and safety of ZM-H1505R in Chronic Hepatitis B. The trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ZM-H1505R

Snippet

Sponsor: Shanghai Zhimeng Biopharma, Inc. | Conditions: Chronic Hepatitis B | Phase 3 | Status: NOT_YET_RECRUITING